Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (BME) Stock Overview

Explore BlackRock Health Sciences Trust’s financial performance, market position, analyst ratings, and future outlook.

BME●NYSE
Financial ServicesAsset Management
$46.25
$0.12(0.26%)
U.S. Market is Open · 15:19

BlackRock Health Sciences Trust (BME)

Meyka AI Score

Z

Key Financials

Market Cap593.2M
P/E Ratio7.71
EPS (TTM)$0.62
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$45.07
3 Months$46.75
1 Year Target$44.05

BME Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of BlackRock Health Sciences Trust (NYSE: BME) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, BlackRock Health Sciences Trust's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BME on the NYSE shows an RSI of 72.65, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $44.05 for the NYSE listing.

Key metrics behind BlackRock Health Sciences Trust's NYSE-traded stock include a P/E ratio of 7.71 and a market capitalization of 593.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BME on the NYSE.

Price Performance (NYSE: BME)

1-Day Change
-0.50%
5-Day Change
1.55%
1-Month Change
7.12%
3-Month Change
15.88%
6-Month Change
8.56%
Year-to-Date (YTD) Change
11.60%
1-Year Change
25.72%
3-Year Change
16.11%
5-Year Change
-5.65%
All-Time (Max) Change
83.60%

Contact Information

https://www.blackrock.com
212 810 5300
100 Bellevue Parkway, Wilmington, NY, 10001

Company Facts

IPO DateMar 29, 2005
CountryUS
Actively Trading

Frequently Asked Questions